These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21205142)

  • 41. [Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations].
    Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Malkowski P; Pawlowska M; Simon K;
    Pol Merkur Lekarski; 2010 Aug; 29(170):103-6. PubMed ID: 20842822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
    Petersen J; Dandri M
    Liver Int; 2015 Jan; 35 Suppl 1():114-20. PubMed ID: 25529096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.
    Jones J; Colquitt J; Shepherd J; Harris P; Cooper K
    Health Technol Assess; 2010 May; 14 Suppl 1():23-9. PubMed ID: 20507800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection.
    Aspord C; Bruder Costa J; Jacob MC; Dufeu-Duchesne T; Bertucci I; Pouget N; Brevot-Lutton O; Zoulim F; Bourliere M; Plumas J; Leroy V;
    PLoS One; 2016; 11(6):e0156200. PubMed ID: 27281019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs.
    Petersen J; Buti M
    Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):683-93; quiz 694. PubMed ID: 23237254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.
    Ridruejo E
    World J Gastroenterol; 2014 Jun; 20(23):7169-80. PubMed ID: 24966587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of chronic hepatitis B infection: an update of Swedish recommendations.
    Lindh M; Uhnoo I; Bläckberg J; Duberg AS; Friman S; Fischler B; Karlström O; Norkrans G; Reichard O; Sangfeldt P; Söderström A; Sönnerborg A; Weiland O; Wejstål R; Wiström J
    Scand J Infect Dis; 2008; 40(6-7):436-50. PubMed ID: 18584530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
    Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
    J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
    Güzelbulut F; Ovünç AO; Oetinkaya ZA; Senates E; Gökden Y; Saltürk AG; Sezikli M; Ozkara S; Cetinkaya F
    Hepatogastroenterology; 2012; 59(114):477-80. PubMed ID: 21940383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B].
    Bai HL; Luo HT; Ye YN; Long H; Zhong RX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):230-1. PubMed ID: 21186536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies.
    Arama V; Leblebicioglu H; Simon K; Zarski JP; Niederau C; Habersetzer F; Vermehren J; Bludzin W; Jinga M; Ulusoy S; Klauck I; Morais E; Bjork S; Lescrauwaet B; Kamar D; Zeuzem S;
    Antivir Ther; 2014; 19(3):245-57. PubMed ID: 24343051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.
    Boglione L; D'Avolio A; Cariti G; Gregori G; Burdino E; Baietto L; Cusato J; Ghisetti V; De Rosa FG; Di Perri G
    Liver Int; 2013 Apr; 33(4):580-5. PubMed ID: 23311449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current treatment of hepatitis B infection: where do the new nucleos(t)ide analogues fit in?].
    Fuentes Olmo J; Uribarrena Amézaga R
    Gastroenterol Hepatol; 2011; 34(7):492-503. PubMed ID: 21550145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B].
    Hosaka T; Suzuki F; Kumada H
    Nihon Shokakibyo Gakkai Zasshi; 2011 Feb; 108(2):210-4. PubMed ID: 21307624
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of delta hepatitis.
    Gunsar F
    Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection.
    Murata K; Tsukuda S; Suizu F; Kimura A; Sugiyama M; Watashi K; Noguchi M; Mizokami M
    Hepatology; 2020 May; 71(5):1533-1545. PubMed ID: 31529730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis: PEG-IFN for the treatment of hepatitis D.
    Ciancio A; Rizzetto M
    Nat Rev Gastroenterol Hepatol; 2011 Jun; 8(6):304-6. PubMed ID: 21643035
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of therapy on the outcome of chronic hepatitis B.
    Liaw YF
    Liver Int; 2013 Feb; 33 Suppl 1():111-5. PubMed ID: 23286854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.